Last viewed: ABT

Prices are updated after-hours

ABT Nyse 2020 - 11 - 04

Abbott Laboratories

ABT | News | $105.9 -3.03% 0.07% 12M

|

Health Technology

(0.0% 1d) (-2.9% 1m) (4.9% 1y) (0.0% 2d) (0.3% 3d) (-2.0% 7d) (NaN% volume)
Earnings Calendar: 2024-01-24
Market Cap: $ 183,756,016,205
http://www.abbott.com
Sec Filling | Patents | 107000 employees

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

cardiovascular nutrition heart optical brands diagnostics

add to watch list Paper trade email alert is off

Press-releases

Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
Published: 2024-04-17 (Crawled : 12:00) - biospace.com/
ABT | News | $105.9 -3.03% 0.07% 12M

|

Health Technology

| 0.58% | O: -0.59% H: 0.0% C: 0.0%
results

Pelthos Therapeutics Establishes Board of Directors
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
ABT | News | $105.9 -3.03% 0.07% 12M

|

Health Technology

| 0.29% | O: -0.29% H: 0.0% C: 0.0%
SVRA | $4.96 -3.88% -4.03% 2.1M

|

Health Technology

| 2.38% | O: -0.79% H: 6.0% C: 3.2%
INSM | $26.18 0.12% 0.11% 1.2M

|

Health Technology

| -2.5% | O: 0.19% H: 0.41% C: -2.68%
therapeutics

STD Testing Market Projected to Reach $14.11 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-13 (Crawled : 04:20) - prnewswire.com
HOLX | $74.91 -0.27% -0.27% 1.7M

|

Health Technology

| Email alert Add to watchlist
ABT | News | $105.9 -3.03% 0.07% 12M

|

Health Technology

| Email alert Add to watchlist
TMO | News | $547.25 -1.32% -0.02% 1.6M

|

Health Technology

| Email alert Add to watchlist
report reach market

AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12 (Crawled : 14:30) - biospace.com/
PRGO | $30.04 0.27% 0.0% 780K

|

Health Technology

| -4.22% | O: -0.13% H: 0.0% C: -2.94%
JNJ | News | $144.77 0.22% -0.01% 9.3M

|

Health Technology

| -4.15% | O: -1.65% H: 0.0% C: 0.0%
ABT | News | $105.9 -3.03% 0.07% 12M

|

Health Technology

| -2.01% | O: -1.06% H: 0.21% C: -1.05%
SNY | News | $46.125 0.71% 0.7% 3.7M

|

Health Technology

| -3.24% | O: -3.02% H: 0.0% C: 0.0%
drug label astrazeneca expansion for kids

Toxicology Testing Market size is set to grow by USD 32.58 billion from 2024-2028, High regulatory compliance in food industry boost the market, Technavio
Published: 2024-04-11 (Crawled : 02:00) - prnewswire.com
WAT | $304.18 -3.04% 0.0% 610K

|

Health Technology

| -6.78% | O: 1.5% H: 0.23% C: -1.07%
TMO | News | $547.25 -1.32% -0.02% 1.6M

|

Health Technology

| -3.95% | O: 0.07% H: 0.0% C: 0.0%
DGX | $126.98 -0.35% -0.18% 890K

|

Health Services

| -3.8% | O: -0.13% H: 0.2% C: -1.71%
LH M | $199.97 -0.97% 0.0% 680K

|

Health Services

| -3.47% | O: -0.61% H: 0.02% C: -0.68%
ABT | News | $105.9 -3.03% 0.07% 12M

|

Health Technology

| -1.76% | O: 0.43% H: 0.3% C: -0.18%
food set market

Consumer Healthcare Market, 33% of Growth to Originate from North America, Technavio
Published: 2024-04-10 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.116 -2.18% 2.3K

|

Health Technology

| -2.26% | O: -100.0% H: NaN% C: Infinity%
JNJ | News | $144.77 0.22% -0.01% 9.3M

|

Health Technology

| -4.76% | O: -0.64% H: 0.0% C: 0.0%
ABT | News | $105.9 -3.03% 0.07% 12M

|

Health Technology

| -1.76% | O: 0.43% H: 0.3% C: -0.18%
SNY | News | $46.125 0.71% 0.7% 3.7M

|

Health Technology

| -3.19% | O: 0.05% H: 0.0% C: 0.0%
growth

Former QuidelOrtho CEO Douglas Bryant Joins Board of Directors of Vital Biosciences
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
ABT | News | $105.9 -3.03% 0.07% 12M

|

Health Technology

| -1.19% | O: 0.06% H: 1.79% C: 1.67%
ceo

Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K

|

Health Technology

| -0.62% | O: 2.24% H: 0.0% C: -0.8%
PRGO | $30.04 0.27% 0.0% 780K

|

Health Technology

| -4.59% | O: 0.96% H: 1.17% C: 0.16%
JNJ | News | $144.77 0.22% -0.01% 9.3M

|

Health Technology

| -5.3% | O: -0.48% H: 0.0% C: 0.0%
ABT | News | $105.9 -3.03% 0.07% 12M

|

Health Technology

| -1.79% | O: 0.09% H: 0.16% C: -0.7%
SNY | News | $46.125 0.71% 0.7% 3.7M

|

Health Technology

| -2.25% | O: 0.84% H: 0.0% C: 0.0%
for

FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K

|

Health Technology

| -4.15% | O: -1.77% H: 0.0% C: -1.81%
PRGO | $30.04 0.27% 0.0% 780K

|

Health Technology

| -4.74% | O: -0.22% H: 0.8% C: 0.06%
JNJ | News | $144.77 0.22% -0.01% 9.3M

|

Health Technology

| -7.04% | O: -1.84% H: 0.0% C: 0.0%
ABT | News | $105.9 -3.03% 0.07% 12M

|

Health Technology

| -0.82% | O: -0.37% H: 1.42% C: 1.37%
SNY | News | $46.125 0.71% 0.7% 3.7M

|

Health Technology

| -5.61% | O: -3.44% H: 0.0% C: 0.0%
fda for

FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | $30.04 0.27% 0.0% 780K

|

Health Technology

| -4.34% | O: -0.29% H: 1.34% C: -0.64%
JNJ | News | $144.77 0.22% -0.01% 9.3M

|

Health Technology

| -8.42% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $105.9 -3.03% 0.07% 12M

|

Health Technology

| -2.51% | O: 0.11% H: 0.37% C: -0.77%
SNY | News | $46.125 0.71% 0.7% 3.7M

|

Health Technology

| -3.84% | O: 0.69% H: 0.0% C: 0.0%
fda drug schizophrenia

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001415889-24-009864	4	2024-04-02	2024-03-31	Buy	A	323	10486
0001415889-24-009863	4	2024-04-02	2024-03-31	Buy	A	310	3650
0001415889-24-009861	4	2024-04-02	2024-03-31	Buy	A	290	3174
0001415889-24-006422	4	2024-03-05	2024-02-29	Sell	F	8339	70365

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

56%

44%

Top 10 Gainers

INVO | $1.76 131.58% 56.82% 230M

|

Health Technology

SINT | $0.0365 59.39% 37.26% 470M

|

Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M

|

Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M

|

GCTK | $0.715 36.27% 26.62% 640K

|

TCON | $2.33 36.26% 26.61% 2M

|

Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M

|

KZIA | $0.38 30.58% 23.42% 300K

|

Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M

|

Health Technology

ATNF | $1.91 29.05% 22.51% 310K

|

Last 48 Hours Insiders Buying

IZEA | $2.5 -2.4% 8.6K

|

Technology Services

| 00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M

|

| 22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K

|

| 22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K

|

Energy Minerals

| 21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M

|

Health Technology

| 16:30
RMCF | $3.51 -3.7% -3.85% 3.8K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar